Saili Medical announced that the company previously implemented centralized auction repurchases from February 6 to April 30, 2024 and June 5 to September 3, 2024, respectively. A total of 3.9777 million shares were repurchased twice, accounting for 1.76% of the company's total share capital. The company disclosed its holdings reduction plan on May 9, 2026, and plans to reduce its holdings by no more than 3.977,700 shares through centralized bidding transactions. As of the date of this announcement, the company has not sold the shares already repurchased as described above. The number of shares reduced is 0. The current number of shares held is 3.977,700 shares, with a shareholding ratio of 1.76%.

Saili Medical announced that the company previously implemented centralized auction repurchases from February 6 to April 30, 2024 and June 5 to September 3, 2024, respectively. A total of 3.9777 million shares were repurchased twice, accounting for 1.76% of the company's total share capital. The company disclosed its holdings reduction plan on May 9, 2026, and plans to reduce its holdings by no more than 3.977,700 shares through centralized bidding transactions. As of the date of this announcement, the company has not sold the shares already repurchased as described above. The number of shares reduced is 0. The current number of shares held is 3.977,700 shares, with a shareholding ratio of 1.76%.